Literature DB >> 8410681

Variability in the renal clearance of cephalexin in experimental renal failure.

A Maïza1, P T Daley-Yates.   

Abstract

This study forms a part of an investigation into the extent to which the type of renal damage influences the renal clearance of drugs. We have already demonstrated an effect of different types of experimental renal failure (ERF) on the renal clearance of two cations: cimetidine, a drug that is filtered and secreted by the nephron, and lithium, which is filtered and reabsorbed by more than one segment of the nephron. In this report the renal clearance of cephalexin (CLCEX) is investigated, a drug that has a different mode of renal elimination, since it is filtered, secreted, and reabsorbed by the proximal tubules. The aim was to extend our earlier studies to an organic anion, and to provide an opportunity to evaluate the feasibility of using the renal clearance of N-1-methylnicotinamide (NMN) to predict the renal clearance of anionic drugs in renal failure. Different models of site-specific ERF have been developed in the rat; proximal tubular necrosis (induced by cisplatin), papillary necrosis (induced by 2-bromoethylamine), and glomerulonephritis (induced by sodium aurothiomalate or by antiglomerular basement membrane antibodies). Glomerular function (GFR) was assessed by the clearance of inulin (CLNULIN), and tubular function was assessed by the clearance of endogenous NMN (CLNMN). OUr results show that even if the models of ERF used were not absolutely site-specific, glomerular function and tubular function did not decrease to the same extent in the different ERF. Therefore, glomerulo-tubular imbalance existed, which is incompatible with the "intact nephron hypothesis," i.e., the site of the damage along the nephron and not only the degree of renal dysfunction, is a potential source of variability in the clearance of certain drugs. The renal clearance of cephalexin was estimated more accurately by CLNMN than GFR (r = 0.90). We conclude that the clearance of the endogenous cation NMN can be used to predict the renal clearance of drugs that are not only filtered by the glomeruli but also secreted and/or reabsorbed by the proximal tubules, and in the limited examples investigated appears to apply to both anionic and cationic compounds. In this respect the GFR alone was not an adequate parameter for the prediction of the renal clearance of such drugs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8410681     DOI: 10.1007/bf01061773

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  33 in total

1.  THE FUNCTIONAL ADAPTATION OF THE DISEASED KIDNEY. I. GLOMERULAR FILTRATION RATE.

Authors:  N S BRICKER; S KLAHR; R E RIESELBACH
Journal:  J Clin Invest       Date:  1964-10       Impact factor: 14.808

2.  Hypothesis for the pathogenesis of sodium aurothiomalate (Myocrisin) induced immune complex nephritis.

Authors:  B Skrifvars
Journal:  Scand J Rheumatol       Date:  1979       Impact factor: 3.641

3.  Fluorimetric assay of cephradine, cephalexin and cephaloglycin.

Authors:  R H Barbhaiya; P Turner
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

4.  Characterization and isolation of specific renal tubular epithelial antigens.

Authors:  T S Edgington; R J Glassock; J I Watson; F J Dixon
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

5.  Toxicology and pharmacology of cephalexin in laboratory animals.

Authors:  J S Welles; R O Froman; W R Gibson; N V Owen; R C Anderson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

6.  Gold nephropathy in rats--light and electron microscopic studies.

Authors:  A H Nagi; F Alexander; A Z Barabas
Journal:  Exp Mol Pathol       Date:  1971-12       Impact factor: 3.362

Review 7.  Renal failure, drug pharmacokinetics and drug action.

Authors:  J Fabre; L Balant
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

8.  Renal function studies in an experimental model of papillary necrosis in the rat.

Authors:  R Vanholder; N Lameire; W Eeckhaut; S Ringoir
Journal:  Arch Int Physiol Biochim       Date:  1981-02

9.  Estimation of renal tubular secretion in man, in health and disease, using endogenous N-1-methylnicotinamide.

Authors:  A Maïza; S Waldek; F W Ballardie; P T Daley-Yates
Journal:  Nephron       Date:  1992       Impact factor: 2.847

10.  Estimation of renal blood flow by use of endogenous N1-methylnicotinamide in rats.

Authors:  C K Shim; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacobiodyn       Date:  1985-01
View more
  3 in total

Review 1.  Drug interactions at the renal level. Implications for drug development.

Authors:  P L Bonate; K Reith; S Weir
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

2.  A general empirical model for renal drug handling in pharmacokinetic analyses.

Authors:  Daniel F B Wright; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2017-05-10       Impact factor: 4.335

3.  Interethnic differences of PEPT2 (SLC15A2) polymorphism distribution and associations with cephalexin pharmacokinetics in healthy Asian subjects.

Authors:  Rui Liu; Audrey May Yi Tang; Yen Ling Tan; Lie Michael George Limenta; Edmund Jon Deoon Lee
Journal:  Eur J Clin Pharmacol       Date:  2008-09-03       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.